SCHEMBL6345470

SCHEMBL6345470

CCCc1c(N)nc(N)nc1-c1ccc(N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 2/20 0.47
BLM P54132 1/20 0.47
HEXA P06865 3/20 0.45
HEXB P07686 3/20 0.45
ALDH1A1 P00352 3/20 0.45
DHFR P00374 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.39
NOS2 P35228 1/20 0.39
CYP2D6 P10635 2/20 0.38
TLR8 Q9NR97 1/20 0.37
SLC22A1 O15245 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28043971 0.78 HEXA (0.55) KMT2AMEN1HEXAHEXBALDH1A1
SCHEMBL6344234 0.76 CYP2D6 (0.67) KMT2AMAPTMEN1BLMALDH1A1
SCHEMBL6348834 0.75 HEXA (0.77) KMT2AMEN1HEXAHEXBALDH1A1
SCHEMBL28043944 0.73 HEXA (0.50) KMT2AMAPTHEXAHEXBALDH1A1
SCHEMBL16703412 0.72 HEXA (0.51) HEXAHEXBDHFRCYP2D6TLR8
SCHEMBL28151078 0.71 DHFR (0.57) MAPTHEXAHEXBALDH1A1DHFR
SCHEMBL27612570 0.71 MAPT (0.53) KMT2AMAPTMEN1BLMALDH1A1
SCHEMBL27544017 0.70 HEXA (0.49) HEXAHEXBDHFRNOS2
Hydrochloric Acid SCHEMBL28757234 0.69 MAPT (0.51) KMT2AMAPTMEN1BLMALDH1A1
SCHEMBL12495989 0.68 ADORA2A (0.51) TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171131-A1 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists KOSOGOF CHRISTI (US) 2005-08-04 US disclosed
US-20050070712-A1 Pyrimidine derivatives as ghrelin receptor modulators ABBOTT LABORATORIES 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171131-A1 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists GHSR, GIPR, GPR119 KMT2A 950/4885MAPT 4601/4885MEN1 1738/4885
US-20050070712-A1 Pyrimidine derivatives as ghrelin receptor modulators GPR119, GIPR, GCGR KMT2A 2596/4885MAPT 4420/4885MEN1 3951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.